365 related articles for article (PubMed ID: 28144802)
21. Management of AML: who do we really cure?
Liesveld J
Leuk Res; 2012 Dec; 36(12):1475-80. PubMed ID: 22938830
[TBL] [Abstract][Full Text] [Related]
22. Induction therapy in acute myeloid leukemia: Is it time to put aside standard 3 + 7?
Ferrara F; Vitagliano O
Hematol Oncol; 2019 Dec; 37(5):558-563. PubMed ID: 30938858
[TBL] [Abstract][Full Text] [Related]
23. The response to induction therapy is crucial for the treatment outcomes of elderly patients with acute myeloid leukemia: single-institution experience.
Tasaki T; Yamauchi T; Matsuda Y; Takai M; Ookura M; Lee S; Tai K; Ikegaya S; Kishi S; Yoshida A; Urasaki Y; Iwasaki H; Ueda T
Anticancer Res; 2014 Oct; 34(10):5631-6. PubMed ID: 25275066
[TBL] [Abstract][Full Text] [Related]
24. Selecting initial treatment of acute myeloid leukaemia in older adults.
Podoltsev NA; Stahl M; Zeidan AM; Gore SD
Blood Rev; 2017 Mar; 31(2):43-62. PubMed ID: 27745715
[TBL] [Abstract][Full Text] [Related]
25. The blind men and the AML elephant: can we feel the progress?
Tauro S
Blood Cancer J; 2016 May; 6(5):e424. PubMed ID: 27176800
[TBL] [Abstract][Full Text] [Related]
26. Acute Myeloid Leukemia: Past, Present, and Prospects for the Future.
Short NJ; Ravandi F
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16 Suppl():S25-9. PubMed ID: 27521321
[TBL] [Abstract][Full Text] [Related]
27. Recent developments in the treatment of older individuals with acute myeloid leukemia: 2014.
Michaelis LC; Erba HP
Curr Opin Hematol; 2015 Mar; 22(2):108-15. PubMed ID: 25603478
[TBL] [Abstract][Full Text] [Related]
28. The safety of treatment options for elderly people with acute myeloid leukemia.
Thomas X; Le Jeune C
Expert Opin Drug Saf; 2016 May; 15(5):635-45. PubMed ID: 26943698
[TBL] [Abstract][Full Text] [Related]
29. Treatment options for older unfit patients with acute myeloid leukemia.
Tang H; Jia S; Bi L; Jia W; Gao G
Future Oncol; 2021 Mar; 17(7):837-851. PubMed ID: 33522289
[TBL] [Abstract][Full Text] [Related]
30. The artful management of older patients with acute myeloid leukemia.
Yang J; Schiffer CA
Expert Rev Hematol; 2016 May; 9(5):425-32. PubMed ID: 26878693
[TBL] [Abstract][Full Text] [Related]
31. Acute myeloid leukemia.
Stone RM; O'Donnell MR; Sekeres MA
Hematology Am Soc Hematol Educ Program; 2004; ():98-117. PubMed ID: 15561679
[TBL] [Abstract][Full Text] [Related]
32. Intensive chemotherapy and reduced-intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in elderly patients.
Jackson K; Kennedy G; Mollee P; Marlton P; Morris K
Asia Pac J Clin Oncol; 2014 Sep; 10(3):246-54. PubMed ID: 24673966
[TBL] [Abstract][Full Text] [Related]
33. Counterpoint: Standard vs Investigational Agents as Upfront Treatment for High-Risk AML.
Brunner AM; Stock W
Oncology (Williston Park); 2017 Mar; 31(3):190, 192. PubMed ID: 28299756
[No Abstract] [Full Text] [Related]
34. Point: Standard vs Investigational Agents as Upfront Treatment for High-Risk AML.
Schiffer CA
Oncology (Williston Park); 2017 Mar; 31(3):190-1. PubMed ID: 28299755
[No Abstract] [Full Text] [Related]
35. Non-intensive acute myeloid leukemia therapies for older patients.
Babakhanlou R; Ravandi-Kashani F
Expert Rev Hematol; 2023 Mar; 16(3):171-180. PubMed ID: 36864772
[TBL] [Abstract][Full Text] [Related]
36. Current clinical strategies and emergent treatment landscapes in leukemic transformation of Philadelphia-negative myeloproliferative neoplasms.
Abruzzese E; Niscola P
Expert Rev Hematol; 2020 Dec; 13(12):1349-1359. PubMed ID: 33226274
[No Abstract] [Full Text] [Related]
37. Finding the optimal combination therapy for the treatment of newly diagnosed AML in older patients unfit for intensive therapy.
Erba HP
Leuk Res; 2015 Feb; 39(2):183-91. PubMed ID: 25577399
[TBL] [Abstract][Full Text] [Related]
38. Acute myeloid leukemia in the elderly: do we know who should be treated and how?
Nazha A; Ravandi F
Leuk Lymphoma; 2014 May; 55(5):979-87. PubMed ID: 23885839
[TBL] [Abstract][Full Text] [Related]
39. Acute myeloid leukemia in the elderly (age 70 yr or older): long-term survivors.
Heiblig M; Elhamri M; Le Jeune C; Laude MC; Deloire A; Wattel E; Salles G; Thomas X
Eur J Haematol; 2017 Feb; 98(2):134-141. PubMed ID: 27717105
[TBL] [Abstract][Full Text] [Related]
40. Acute myeloid leukemia in the elderly: what constitutes treatment value?
Nabhan C; Kamat S; Karl Kish J
Leuk Lymphoma; 2019 May; 60(5):1164-1170. PubMed ID: 30407103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
